United States · Bill · HR
H.R. 1362 (116th)
Medical Innovation Never Stops Act of 2019
Introduced
26 February 2019
Last action
27 February 2019 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Tom Emmer
Subjects
Healthcare
Source updated
7 April 2025
Summary
Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA) to accept and review new medical device applications and associated user fees during a lapse in appropriations. Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
26 February 2019
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
26 February 2019
Introduced
Introduced in House
Source: IntroReferral
26 February 2019
Introduced
Introduced in House
Source: IntroReferral
27 February 2019
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 26 February 2019 · Official file
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 26 February 2019
Introduced in House (PDF)
Introduced in House · EN · 26 February 2019
Introduced in House
summary · EN · 26 February 2019
Sponsors
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/1362
- Open data entity: https://api.congress.gov/v3/bill/116/hr/1362
- us · 116-hr-1362 · source updated 7 April 2025